Harvey, N.C. http://orcid.org/0000-0002-8194-2512
Kanis, J.A.
Liu, E.
Johansson, H.
Lorentzon, M.
McCloskey, E.
Article History
Received: 1 November 2018
Accepted: 14 February 2019
First Online: 27 February 2019
Compliance with ethical standards
:
: NCH has received consultancy/lecture fees/honoraria/grant funding from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Consilient Healthcare and Internis Pharma. EVM has received consultancy/lecture fees/grant funding/honoraria from ActiveSignal, AgNovos, Amgen, AstraZeneca, Consilient Healthcare, Gilead, GSK, Hologic, Internis, Lilly, Medtronic, Merck, Novartis, Pfizer, Radius Health, Redx Oncology, Roche, Sanofi-Aventis, Servier, Synexus, Tethys, UCB, Viiv, Warner Chilcott, I3 Innovus and Unilever. ML has received lecture or consulting fees from Amgen, Lilly, Meda, UCB Pharma, Renapharma, Radius Health and Consilient Health. JAK reports grants from Amgen, Lilly and Radius Health, and consulting fees from Meda; he is the architect of FRAX but has no financial interest. HJ and EL have nothing to disclose.